Sign In
Buy ZVSA
$0.170
-0.0002 (-0.118%)
At Close: Jun 02, 2026
Why Is ZyVersa Therapeutics (ZVSA) Stock Down 44% Today?
09:07am, Thursday, 07'th Dec 2023
ZyVersa Therapeutics (NASDAQ: ZVSA ) stock is sliding lower on Thursday after the clinical-stage biopharmaceutical company priced a public share offering. ZyVersa Therapeutics is offering 4 million s
Why Is ZyVersa Therapeutics (ZVSA) Stock Up 27% Today?
09:54am, Wednesday, 06'th Dec 2023
ZyVersa Therapeutics (NASDAQ: ZVSA ) stock is rising higher on Wednesday after the clinical-stage specialty biopharmaceutical company highlighted the publication of a paper in a peer-reviewed journal.
Why Is ZyVersa Therapeutics (ZVSA) Stock Down 46% Today?
08:51am, Wednesday, 26'th Apr 2023
ZyVersa Therapeutics (NASDAQ: ZVSA ) stock is sliding lower on Wednesday following a couple of announcements from the company. The first is the company's publication of an article in the peer-reviewe
ZyVersa Therapeutics' CEO, Stephen C. Glover, to Present at Planet MicroCap Showcase
09:07am, Tuesday, 11'th Apr 2023
WESTON, Fla., April 11, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for t
Why Is ZyVersa Therapeutics (ZVSA) Stock Up 35% Today?
08:08am, Thursday, 23'rd Mar 2023
ZyVersa Therapeutics (NASDAQ: ZVSA ) stock is taking off on Thursday without any recent news from the biopharmaceutical company. Instead, it looks like investors can thank heavy pre-market trading for
Why Is ZyVersa Therapeutics (ZVSA) Stock Up 94% Today?
08:08am, Thursday, 02'nd Feb 2023
ZyVersa Therapeutics (NASDAQ: ZVSA ) stock is flying higher on Thursday as investors react to a preliminary prospectus for a stock offering. The stock offering announced by ZyVersa Therapeutics covers
ZyVersa Therapeutics to Present at BIO CEO & Investor Conference
09:45am, Wednesday, 25'th Jan 2023
WESTON, Fla., Jan. 25, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for th
ZyVersa Therapeutics' CEO, Stephen C. Glover, to Present at the Virtual Investor 2023 Companies to Watch Event
02:45pm, Wednesday, 11'th Jan 2023
Live video webcast on Wednesday, January 18th at 2:00 PM ET
